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Experimental studies have demonstrated that TNFa/cachectin is an important
mediator in septic shock (1-3), and that IL-1 synergizes withTNFa in producing
lung tissue damage and lethal shock (4, 5). Furthermore, previous studies haveshown
that the systemic release ofTNFa (6), IL-1 (7, 8), and IL-6 (8) is associated with
septic shock and fatal outcome in patients with meningococcal disease.
However, many of the activities ofTNFa, IL-1, and IL-6 indicate a local rather
than a systemic production and function of these cytokines. TNFa and IL-1 may
recruit granulocytes to the site of inflammation by margination of granulocytes in
the blood stream (9, 10) and chemotactic effect (11, 12).TNFa induces the produc-
tion oftoxic oxygen radicals (13)and augments the phagocytosis by neutrophils (14),
which may be important in the inflammatory response . IL-6 is locally produced in
arthritis (15) and in bacterial meningitis (16), and induces growth ofB lymphocytes
(17) . Furthermore, IL-6 sharesmany ofits biological activities withTNFaand IL-1
(18), andprobably, allthree cytokines actinanetworkof factorsdirectingthe inflam-
matory reaction .
Meningococcal.disease includes avarietyof clinical syndromes ofwhich thedom-
inantmanifestations arelocalmeningitis, andbacteremia with or withoutseptic shock .
Whereas the roles of TNFa and in part IL-1 in septic shock have been clarified,
their functions in meningococcal meningitis remain unclear .
In this study we demonstrate that TNFa, IL-1, and IL-6 can be detected in
cerebrospinal fluid (CF)' in patients with meningococcal meningitis, and that
meningococcal LPSor viable meningococci trigger thesequential releaseofTNFa,
IL-1, and IL-6 activities in CF in rabbits before infiltration of leukocytes . The sub-
arachnoid space and systemic circulation are functionally separate compartments
with respect to production of TNFa, IL-1, and IL-6 .
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Materials and Methods
Patients.
￿
CF was obtained from 32 men and 28 women on admission to the university
hospitals in Bergen, Oslo (Ulleval), and Trondheim during 1982-87. The age range was 2-93
yr; 63% of the patients were 10-20 yr old. The clinical diagnosis of meningococcal disease
was confirmed bacteriologically (56 patients) or serologically. Patients were considered to have
bacteremia if blood cultures were positive, meningitis if CF contained >108 cells/liter, and
septic shock if systolic blood pressure was <70 mm Hg (<12 yr old), or <100 mm Hg (>12
yr old).
The patients had these manifestations: meningitis (n = 33), septic shock (n = 9), septic
shock and meningitis (n = 11), and bacteremia without meningitis or shock (n = 7).
CF was also obtained from 91 patients with nonbacterial neurological diseases, including
cerebrovascular disease, brain tumor, disseminated sclerosis, back pain, and headache. All
samples of CF were stored at -70°C until they were assayed for cytokines and LPS.
Assaysfor TNF-a, IL-1, and IL-6.
￿
TNRa was determined by its cytotoxic effect on the
mouse fibrosarcoma cell line WEHI 164 clone 13, essentially as previously described (19).
Dilutions of human rTNFa (Genentech Inc., South San Francisco, CA; supplied by Dr. G.
Adolf, Boehringer Ingelheim, Vienna, Austria) were included as a standard. The detection
limit of the assay was 2-3 pg of rTNFa/ml CF. All samples were assayed the same assay
day. The addition of a rabbit antiserum to rTNFu (19) (neutralizing capacity, 600 ng rTNF
a/ml) completely neutralized the cytotoxicity in the patient samples. TNFci activity in samples
ofCF from rabbits was completely neutralized by a goat antiserum to rTNFat (kindly provided
by Dr. J. Mathison, Research Institute of Scripps Clinic, LaJolla, CA). This antiserum has
previously been demonstrated to neutralize rabbit TNFci (20).
IL-1 was determined in a two step assay using the T cell lines NOB 1 (21), which produces
IL-2 upon exposure to IL-1, and HT 2 (22), which requires IL-2 to grow. Triplicate test samples
were fourfold serially diluted in 96-well microtiter plates (100 gl/well), and 100 pl ofa NOB
1 cell suspension (2 x 106 cells/ml) was added to each well. Medium consisted ofRPMI 1640
(Gibco Laboratories, Grand Island, NY), 10% FCS (Hyclone Laboratorium Inc., Logan,
UT), 2 mmol/liter glutamine, and 30 jig/ml of gentamicin. After 24 h, the plates were cen-
trifuged, and 100 jul of the supernatant was added to HT 2 cells (100 pl/well, 1.5 x 105
cells/ml) in a microtiter plate. After 24 h, cell growth was estimated by adding a tetrazolium
salt, as described (23). rIL-1,Q (24) (kindly provided by Dr. A. Shaw, Glaxo Institute for Mo-
lecular Biology, Geneva, Switzerland) was included as a standard, and the detection limit
of the assay was -30 pg of rIL-la/ml CF. Antiserum to rIL-la and rIL-1f have previously
been raised in sheep, and neutralized 20 hg of rIL-la/ml and 2 kg of rIL-1S/ml (gift from
Dr. A. Shaw). A mixture of these antisera was added to positive patient samples, and it neu-
tralized completely the IL-1 activity.
IL-6 was determined by the IL-6-dependent mouse hybridoma cell line B9, (kindly provided
by Dr. L. Aarden, University ofAmsterdam, The Netherlands) as previously described (25).
In short, serial dilutions oftriplicate test samples were incubated for 72 h with B9 cells. Dilu-
tions of rIL-6 (26) were included as a standard. Cell growth was measured as described (23).
The detection limit of the assay was -15 pg of rIL-6/ml CF. All samples were assayed the
same assay day. A rabbit antiserum to rIL-6 (gift from Dr. W. Fiers, University of Gent,
Belgium) neutralized 400 ng of rIL-6/ml when tested in the B9 cell assay. This antiserum
completely neutralized the growth stimulatory effect of the patient samples.
Assayfor LPS
￿
LPS was measured with the chromogenic Limulus amebocyte lysate test,
as described in detail (27). The detection limit of the assay was -25 pg/ml (LPS from Esche-
richia coli 055B5; Mallinckrodt, St. Louis, MO).
Protein, Glucose, Leukocytes.
￿
Samples ofhuman CF were analyzed by routine methods used
in the clinical laboratories. Protein levels in rabbit CF were determined by Bio-Rad protein
assay (Bio-Rad Laboratories GmbH, Miinchen, FRG), and leukocytes were counted with
Coulter Counter. Smears were evaluated by May-Grunwald/Giemsa and esterase staining.
Animal Experiments.
￿
Chinchilla rabbits (Chb:cH; Dr. K. Thomae GmbH, Biberach a.d.
Riss, FRG) weighing 2.7-3 .3 kg were anesthetized with fentanyl/fluanison (Hypnorm, Janssen,
Brussel, Belgium) and midozolam (Dormicum, Hoffmann-LaRoche, Basel, Switzerland). TheWAAGE ET AL.
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cisterna magnum was punctured by a 25-gauge needle, and 300 JAI of CF was withdrawn
and replaced by saline containing 1.5 Wg/ml of LPS extracted from N. meningiddis (gift from
K. Bryhn, National Institute of Public Health, Oslo, Norway) or 109 CFU/ml of viable
meningococci (strain 44/76; National Institute of Public Health, Oslo). Samples ofCF were
obtained by repeated punctures of cisterna magnum and centrifugation, and supernatants
were stored at -20°C . Samples were discarded ifcontamination ofwhole blood, as estimated
by optical reading at 450 nm, was above 1/75 . In control experiments, contamination below
this limit did not influence the activity of TNFa, IL-1, and IL-6 or the leukocyte count.
Samples of CF that were assayed for protein contained whole blood <1/300.
Statistical Analysis.
￿
The significance ofdifferences in proportions of samples positive for
TNFa or IL-1 was determined by XZ test or Fisher's exact test. The significance of differ-
ences in concentrations of IL-6 was determined by Mann-Whitney rank sum test. All tests
were two-sided; p values of <0.05 were considered to be statistically significant.
Results
TNF-a, IL-1, and IL-6 in CF .
￿
TNT-a was detected in CF in 24 of 44 (55%) of
the patients with meningitis, and 3 of 16 (19%) of the patients with septic shock/bac-
teremia (Fig. 1). This difference was statistically significant (p = 0.03). Further-
more, patients with meningitis had higher concentrations of TNFa than patients
with septic shock/bacteremia (range 0.003-31 ng/ml versus 0.003-0.9 ng/ml, respec-
tively).
IL-1 was detected in CF in 21 of 42 patients (50%) in patients with meningitis,
9/B
FIGURE 1. Concentrations of
TNFa, IL-1, and IL-6 in sam-
ples of CF obtained from pa-
tients with meningococcal dis-
ease. M denotes patients with
meningitis, and patients with
meningitis and septic shock/
bacteremia; S/B denotes pa-
tients with septic shock or bac-
teremia (without meningitis).
Each dot represents mean of
triplicate determination of the
sample from one patient. The
horizontal bars denote the de-
tection limit of the assays
(-0.003 ng/ml ofrTNFa, 0.03
ng/ml or rIL-1,6, and 0.015
ng/ml of rIL-6).
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and 2 of 13 patients (15%) with septic shockPbacteremia (p = 0.05). Patients with
septic shock/bacteremia had the two highest concentrations of IL-1.
IL-6 was detected in 41 of 42 samples (98%) from patients with meningitis and
in all 15 samples from patients with septic shock/bacteremia. However, the median
values in the two groups were 154 ng/ml (range 0.015-920) and 42 ng/ml (range
0.1-807), respectively. This difference was statistically significant (p = 0.001).
In 91 patients with nonbacterial neurological diseases, TNFa and IL-1 were not
detected in CF IL-6 was detected in CF from six of these patients, but the highest
concentration was only 0.07 ng/ml (data not shown).
These data show that TNFa, IL-1, and IL-6 can be detected in the CF in patients
with meningococcal disease, and that patients with meningitis more frequently have
TNFa and IL-1 and higher concentrations of IL-6 in the CF than patients with
septic shock/bacteremia.
Cytokines in Relation to Inflammation Parameters.
￿
The LPS concentration, the pro-
tein concentration, and leukocyte count in the CFs and the blood/CF glucose were
determined (data not shown), and we analyzed the correlations between these
parameters and the levels of cytokines in the CF (Table I). The levels of TNFa,
IL-1, and IL-6 correlated with each other by significantly positive (p < 0.01) correla-
tion coefficients between 0.34 and 0.54. High concentration ofLPS and low CF/blood
glucose are considered to be indicators of high number of bacteria present in the
CF The CF/blood glucose inversely correlated with the three cytokines (r = -0.34
to -0.67, p < 0.01), whereas only the TNFa level positively correlated with the LPS
level (r = 0.91, p < 0.001). Leakage of serum proteins and migration of leukocytes
into the CF compartment are characteristics of the inflamed meninges. The level
ofall the cytokines correlated with the protein concentration in the Us (r = 0.34-0.62,
p < 0.01), but only the level of IL-6 correlated with the cell count (r = 0.37, p < 0.01).
Experimental Meningitis in Rabbits.
￿
On admission to the hospital, patients were
in different stages ofthe development of the inflammatory reaction of the meninges.
To better understand the data obtained in these patients, a rabbit model was devel-
oped to study the kinetics of production and elimination of TNFa, IL-1, and IL-6,
infiltration of leukocytes and increase of protein in the CF Meningococcal LPS or
viable meningococci were injected into the subarachnoid space, and thereafter, con-
secutive samples ofCF were drawn, and analyzed for the relevant parameters. Results
from one rabbit are shown in Fig. 2, and demonstrate that TNFa, IL-1, and IL-6
' P < 0.01.
i P < 0.001.
TABLE I
Correlations between Cytokine Levels in CF and Other
Inflammatory Parameters
TNF-a
IL-1
0.34'
IL-6
0.38'
LPS
0.911
Blood/CF
glucose
r
-0.42'
Protein
0.431
Leukocyte
count
0.01
IL-1 - 0.541 0.04 -0.34' 0.34' 0.16
IL-6 - - 0.18 -0.671 0.621 0.37'E
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activities were detected respectively 1/2, 1, and 3 h after injection ofLPS. Asmall
increase ofleukocytes was observed after 2 and 3 h, but the main infiltration ofcells
startedafter 4 h. The protein concentration was elevated 1 h after injection ofLPS,
continued to rise for 6 h, and elevated levels persisted for at least 12 h.
The sequentialappearanceofTNFa, IL-1, and IL-6bioactivity followedby migra-
tion ofleukocytes was reproduced in 10 rabbit experiments. In some ofthe rabbits,
high leukocyte counts persisted for >24 h. Differential counts consistently showed
that >95% ofthe cells in the CF were neutrophils within 8 h afterinjection; there-
aftertherewasan increase in thenumberofmononuclearcells to 20-30% after 14h.
The point oftime for appearance of IL-1 activity varied by 1-3 h, and a corre-
sponding variation was observed for IL-6. In some rabbits near maximal activities
ofIL-1 and IL-6persistedforseveralh. There wasnodifference inthe kinetics curves
ofthe cytokines, orthe sequence oftheirreleasewhether LPSorviable meningococci
were injected (data not shown). TNFa, IL-1, or IL-6 bioactivity was not detected
after injection of LPS-free saline into the subarachnoid space.
These data show that LPS or viable meningococci trigger the sequential release
of TNFa, IL-1, and IL-6 activities in the CF before infiltration of leukocytes.
Induction of Cytokines in the Subarachnoid Space and in the Systemic Circulation.
￿
When
LPSwas injected into thesubarachnoid space, TNFciactivity wasdetected in serum1864
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at concentrations <1/1,000 ofthose in the CF (Fig. 3, right). IL-1 and IL-6 activities
were not detected in serum. Conversely, whenLPS wasinjected intravenously, TNFa
activity was detected in the CF at concentrations <1/100 ofthose in serum (Fig. 3,
left), whereas IL-1 and IL-6 activities were not detected in the CF. TNFa activity
in CF after intravenous injection ofLPS mighthave been caused bycontamination
ofserum in the course of the sampling procedure. There was no cellular reaction
in CF after intravenous injection ofLPS. The kinetics ofproduction and clearance
ofTNFa was similar in the circulation and the subarachnoid space after injection
of LPS in the respective compartments.
The data demonstrate that the subarachnoid space and the circulation are sepa-
rate compartments with respect to production of TNFa, IL-1, and IL-6.
Discussion
Thisstudydemonstrates thatTNFa, IL-1, andIL-6 arereleasedinto thesubarach-
noid space in patients with meningococcal meningitis, and that the subarachnoid
spaceand systemic circulationaredistinct compartments withrespecttotheproduction
ofTNFa, IL-1, and IL-6. In rabbits, TNFaactivity wasdetected inthe CFalready
30min afterthe injection ofLPS, whereasIL-1 and IL-6 activity were released later
than TNFa, butbefore the presenceofleukocytes. This indicatesthatthe cytokines
are released from cells normally present in the CFcompartment, and not by leuko-
cytes migrating from the systemic circulation.
We have previously observed that patients with meningococcal septic shock and
TNF-a serum levels >140 pg/ml, invariably died (6), and that the presence ofboth
TNFa and IL-1 in the circulation is particularly potent in inducing lethal shock
(5, 8). In contrast, the TNFa level in CF was >140 pg/ml in all 14 patients with
meningitis (without septic shock/bacteremia), andthesepatientsalsohaddetectable
levels ofIL-1 inthe CF. However, noneofthese patientsdied, and obviously, TNFa
and IL-1 induce entirely different reactions when present in the CF compartment
and systemic circulation.
The rabbit model proved to be well suited to monitor the cytokine response in
meningitis. The sequential release ofTNFa and IL-6 has also been demonstrated
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FIGURE 3.
￿
TNFa in serum and CF after injec-
tion ofmeningococcal LPS in thesystemic circu-
lation (left) and in the subarachnoid space (right).
5 wg of LPS was injected intravenously, and 0.5
Wg was injected into the subarachnoid space.
Results from one rabbit are shown in each panel.
Each point on the curves represents mean oftripli-
cate determination.WAAGE ET AL.
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in the systemic circulation in humans (8, 28). In the present study we were also
able toconsistently determine therelease ofIL-1 activity afterthe releaseofTNFa,
and clearly, the sequential releases of TNFu, IL-1, and IL-6 activities are initial
events in meningococcal meningitis in rabbits.
The analysis of the relation between the various parameters of inflammation in
humans, is confused by two conditions: (a) the patientshad avariable preadmission
historyofmeningococcaldisease, and the samples ofCFwere thustakenat different
time points in relation to theinduction ofcytokines, and (b) thekinetics ofproduc-
tionofTNFa, IL-1, and IL-6 in CF inmeningococcal meningitis in humans isun-
known. However, the intermediate positivecorrelation coefficients found forthe re-
lations between TNFac, IL-1, and IL-6 (Table I) are consistentwith an overlapping
presence ofTNFa, IL-1, and IL-6 in the CF, and a sequential release as demon-
strated inthe rabbit. Furthermore, the concentration ofproteinpositively correlated
with all the cytokines, whereas the leukocyte count positively correlated only with
the level ofIL-6. This is consistent with an earlyand persistent increase in the pro-
tein concentration and alater increase in IL-6 level and leukocyte count. Our data
thusindicatethatthesequenceofinitialevents intheinflammatory response in menin-
gococcal meningitis is similar in humans and rabbits.
In conclusion, this studyestablishes that TNFa, IL-1, and IL-6 are released into
the subarachnoid space in meningococcal meningitis, and demonstrates that a se-
quential release ofTNFa, IL-1, and IL-6 activities precedes the cellular infiltration
in experimental meningitis. The results further demonstrate the versatile role of
TNFa, IL-1, and IL-6 in meningococcal disease. When present in the circulation,
thecytokinesmaybeimplicated inthe complex pathogenesis ofseptic shock, whereas
their functions in the CF compartment, even at veryhigh concentrations, probably
are confined to the local inflammatory reaction (29).
Summary
We examined the cerebrospinal fluid (CF) taken on admission from 60 patients
with infections caused by Neisseria meningitidis for presence of TNFa, IL-1, and
IL-6. TNF-ci was detected in CF in 55 and 19% (p = 0.03), IL-1 in 50 and 15%
(p = 0.05), and IL-6 in 98 and 100% ofpatients with meningitis and septic shock/
bacteremia, respectively. Themedian IL-6concentration in CF inpatients with men-
ingitis was 154 ng/ml, and in patients with septic shock/bacteremia it was 42 ng/ml
(P = 0.001).
The level of LPS in CF correlated with the level ofTNFa (r = 0.91, p < 0.001),
but not with the level of IL-1 and IL-6. CF levels of TNF-a, IL-1, and IL-6 cor-
related with each other (r = 0.34-0.54, p < 0.01), with the protein concentration
(r = 0.34-0.62, p < 0.01) and inversely with the CF/blood glucose ratio (r = -0.34
to -0.67, p < 0.01). Only the IL-6 level correlated with the leukocyte count (r =
0.37, p < 0.01).
In rabbits TNFa, IL-1, and IL-6 activities sequentially appeared in CF within
3 h of injection of meningococcal LPS or viable meningococci, whereas the main
infiltration ofgranulocytes started after 4 h. TNFce was detected in serum at con-
centrations <1/1,000 ofthose in CF after administration ofLPS into the subarach-
noid space, and conversely, TNFa was detected in CF at concentrations 1/100 of
those in serum after intravenous injection of LPS.1866￿
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The results demonstrate that TNFa, IL-1, and IL-6 are sequentially produced
inthe initial phase ofthelocal inflammatory responsecaused bymeningococci, and
that the subarachnoid space and systemic circulation are separate compartments
with respect to production ofTNFa, IL-1, and IL-6.
We thankDr.J. Lamvik forstimulatingcriticismofthemanuscript; Dr.TSandforproviding
samples ofCF from neurological patients; Dr.J. Meland for the maintenance ofthe strain
ofN. meningitides; M. Sorensen, B. Stordal, andA. Krogh-Mo fortheirtechnical assistance.
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